{"pmid":32234116,"title":"Coronavirus disease (COVID-19) Community Testing Team in Scotland: A 14-day review, 6 to 20 February 2020.","text":["Coronavirus disease (COVID-19) Community Testing Team in Scotland: A 14-day review, 6 to 20 February 2020.","In response to the outbreak of COVID-19, we set up a team to carry out sampling in the community. This enabled individuals to remain in self-isolation in their own homes and to prevent healthcare settings and services from being overwhelmed by admissions for sampling of suspected cases. There is evidence that this is a cost effective, safe and necessary service to complement COVID-19 testing in hospitals.","Euro Surveill","Mark, Kate","Steel, Katie","Stevenson, Janet","Evans, Christine","McCormick, Duncan","Willocks, Lorna","McCallum, Alison","Jones, Laura","Johannessen, Ingolfur","Templeton, Kate","Koch, Oliver","Mackintosh, Claire","32234116"],"abstract":["In response to the outbreak of COVID-19, we set up a team to carry out sampling in the community. This enabled individuals to remain in self-isolation in their own homes and to prevent healthcare settings and services from being overwhelmed by admissions for sampling of suspected cases. There is evidence that this is a cost effective, safe and necessary service to complement COVID-19 testing in hospitals."],"journal":"Euro Surveill","authors":["Mark, Kate","Steel, Katie","Stevenson, Janet","Evans, Christine","McCormick, Duncan","Willocks, Lorna","McCallum, Alison","Jones, Laura","Johannessen, Ingolfur","Templeton, Kate","Koch, Oliver","Mackintosh, Claire"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32234116","week":"202014|Mar 30 - Apr 05","doi":"10.2807/1560-7917.ES.2020.25.12.2000217","keywords":["COVID-19","community","containment","sampling"],"source":"PubMed","locations":["GBR"],"countries":["United Kingdom"],"countries_codes":["GBR|United Kingdom"],"topics":["Prevention"],"weight":1,"_version_":1662996001676328962,"score":7.6048946,"similar":[{"pmid":32166310,"title":"A Novel Approach for a Novel Pathogen: using a home assessment team to evaluate patients for 2019 novel coronavirus (SARS-CoV-2).","text":["A Novel Approach for a Novel Pathogen: using a home assessment team to evaluate patients for 2019 novel coronavirus (SARS-CoV-2).","Thousands of people in the United States have required testing for SARS-CoV-2. Evaluation for a special pathogen is resource intensive. We report an innovative approach to home assessment that, in collaboration with public health, enables safe evaluation and specimen collection outside the healthcare setting, avoiding unnecessary exposures and resource utilization.","Clin Infect Dis","Bryson-Cahn, Chloe","Duchin, Jeffrey","Makarewicz, Vanessa A","Kay, Meagan","Rietberg, Krista","Napolitano, Nathanael","Kamangu, Carole","Dellit, Timothy H","Lynch, John B","32166310"],"abstract":["Thousands of people in the United States have required testing for SARS-CoV-2. Evaluation for a special pathogen is resource intensive. We report an innovative approach to home assessment that, in collaboration with public health, enables safe evaluation and specimen collection outside the healthcare setting, avoiding unnecessary exposures and resource utilization."],"journal":"Clin Infect Dis","authors":["Bryson-Cahn, Chloe","Duchin, Jeffrey","Makarewicz, Vanessa A","Kay, Meagan","Rietberg, Krista","Napolitano, Nathanael","Kamangu, Carole","Dellit, Timothy H","Lynch, John B"],"date":"2020-03-14T11:00:00Z","year":2020,"_id":"32166310","week":"202011|Mar 09 - Mar 15","doi":"10.1093/cid/ciaa256","keywords":["COVID-19","SARS-CoV-2","home assessment","novel coronavirus"],"source":"PubMed","locations":["United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1662334543741321216,"score":130.80447},{"pmid":32244841,"title":"Blockchain and Artificial Intelligence Technology for Novel Coronavirus Disease-19 Self-Testing.","text":["Blockchain and Artificial Intelligence Technology for Novel Coronavirus Disease-19 Self-Testing.","The novel coronavirus disease 19 (COVID-19) is rapidly spreading with a rising death toll and transmission rate reported in high income countries rather than in low income countries. The overburdened healthcare systems and poor disease surveillance systems in resource-limited settings may struggle to cope with this COVID-19 outbreak and this calls for a tailored strategic response for these settings. Here, we recommend a low cost blockchain and artificial intelligence-coupled self-testing and tracking systems for COVID-19 and other emerging infectious diseases. Prompt deployment and appropriate implementation of the proposed system have the potential to curb the transmissions of COVID-19 and the related mortalities, particularly in settings with poor access to laboratory infrastructure.","Diagnostics (Basel)","Mashamba-Thompson, Tivani P","Crayton, Ellen Debra","32244841"],"abstract":["The novel coronavirus disease 19 (COVID-19) is rapidly spreading with a rising death toll and transmission rate reported in high income countries rather than in low income countries. The overburdened healthcare systems and poor disease surveillance systems in resource-limited settings may struggle to cope with this COVID-19 outbreak and this calls for a tailored strategic response for these settings. Here, we recommend a low cost blockchain and artificial intelligence-coupled self-testing and tracking systems for COVID-19 and other emerging infectious diseases. Prompt deployment and appropriate implementation of the proposed system have the potential to curb the transmissions of COVID-19 and the related mortalities, particularly in settings with poor access to laboratory infrastructure."],"journal":"Diagnostics (Basel)","authors":["Mashamba-Thompson, Tivani P","Crayton, Ellen Debra"],"date":"2020-04-05T11:00:00Z","year":2020,"_id":"32244841","week":"202014|Mar 30 - Apr 05","doi":"10.3390/diagnostics10040198","keywords":["artificial intelligence","blockchain","novel coronavirus disease-19","self-testing"],"source":"PubMed","locations":["Blockchain"],"topics":["Diagnosis","Prevention"],"weight":1,"_version_":1663169699625566209,"score":113.92485},{"pmid":32207068,"title":"Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy.","text":["Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy.","Confronting the SARS-CoV-2 outbreak has allowed us to appreciate how efficiently highly-resourced settings can respond to crises. However even such settings are not prepared to deal with the situation, and lessons are only slowly being learnt. There is still an urgent need to accelerate protocols that lead to the implementation of rapid point-of-care diagnostic testing and effective antiviral therapies. In some high-risk populations, such as dialysis patients, where several individuals are treated at the same time in a limited space and overcrowded areas, our objective must be to ensure protection to patients, the healthcare team and the dialysis ward. The difficult Italian experience may help other countries to face the challenges. The experience of the Lombardy underlines the need for gathering and sharing our data to increase our knowledge and support common, initially experience-based, and as soon as possible evidence-based position to face this overwhelming crisis.","J Nephrol","Rombola, Giuseppe","Hedemperger, Marco","Pedrini, Luciano","Farina, Marco","Aucella, Filippo","Messa, Piergiorgio","Brunori, Giuliano","32207068"],"abstract":["Confronting the SARS-CoV-2 outbreak has allowed us to appreciate how efficiently highly-resourced settings can respond to crises. However even such settings are not prepared to deal with the situation, and lessons are only slowly being learnt. There is still an urgent need to accelerate protocols that lead to the implementation of rapid point-of-care diagnostic testing and effective antiviral therapies. In some high-risk populations, such as dialysis patients, where several individuals are treated at the same time in a limited space and overcrowded areas, our objective must be to ensure protection to patients, the healthcare team and the dialysis ward. The difficult Italian experience may help other countries to face the challenges. The experience of the Lombardy underlines the need for gathering and sharing our data to increase our knowledge and support common, initially experience-based, and as soon as possible evidence-based position to face this overwhelming crisis."],"journal":"J Nephrol","authors":["Rombola, Giuseppe","Hedemperger, Marco","Pedrini, Luciano","Farina, Marco","Aucella, Filippo","Messa, Piergiorgio","Brunori, Giuliano"],"date":"2020-03-25T11:00:00Z","year":2020,"_id":"32207068","week":"202013|Mar 23 - Mar 29","doi":"10.1007/s40620-020-00727-y","source":"PubMed","locations":["Italian","Lombardy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1662334543422554112,"score":107.44863},{"pmid":32245691,"title":"On the frontline against COVID-19: Community pharmacists' contribution during a public health crisis.","text":["On the frontline against COVID-19: Community pharmacists' contribution during a public health crisis.","The global spread of COVID-19 is placing unprecedented demands on healthcare services. In this time of crisis, innovative and adaptive methods of practising will be required across all health professions. In order to maximise the use of current available resources, it is vital that existing services are comprehensively reviewed and full use is made of any unrealised potential among healthcare providers. Community pharmacy is one of a number of health professions that has a key role to play in responding to the current pandemic. As the scope of community pharmacy practice varies considerably across countries, it is important to examine ways in which the profession can assist with the public health response to COVID-19 and maintaining the continuity of healthcare services. This article seeks to highlight roles and activities that community pharmacists can undertake to help in relieving pressure on other areas of the health service, such as general practice. This information could help to inform future decisions about the restructuring of existing health services by governments, public health bodies and policy makers in response to public health crises such as COVID-19.","Res Social Adm Pharm","Cadogan, Cathal A","Hughes, Carmel M","32245691"],"abstract":["The global spread of COVID-19 is placing unprecedented demands on healthcare services. In this time of crisis, innovative and adaptive methods of practising will be required across all health professions. In order to maximise the use of current available resources, it is vital that existing services are comprehensively reviewed and full use is made of any unrealised potential among healthcare providers. Community pharmacy is one of a number of health professions that has a key role to play in responding to the current pandemic. As the scope of community pharmacy practice varies considerably across countries, it is important to examine ways in which the profession can assist with the public health response to COVID-19 and maintaining the continuity of healthcare services. This article seeks to highlight roles and activities that community pharmacists can undertake to help in relieving pressure on other areas of the health service, such as general practice. This information could help to inform future decisions about the restructuring of existing health services by governments, public health bodies and policy makers in response to public health crises such as COVID-19."],"journal":"Res Social Adm Pharm","authors":["Cadogan, Cathal A","Hughes, Carmel M"],"date":"2020-04-05T11:00:00Z","year":2020,"_id":"32245691","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.sapharm.2020.03.015","keywords":["COVID-19","Community pharmacy","Coronavirus","Pandemic","Pharmacist","Public health"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663169699693723648,"score":101.64668},{"pmid":32238336,"title":"Global Telemedicine Implementation and Integration Within Health Systems to Fight the COVID-19 Pandemic: A Call to Action.","text":["Global Telemedicine Implementation and Integration Within Health Systems to Fight the COVID-19 Pandemic: A Call to Action.","On March 11, 2020, the World Health Organization declared the coronavirus disease 2019 (COVID-19) outbreak as a pandemic, with over 720,000 cases reported in more than 203 countries as of 31 March. The response strategy included early diagnosis, patient isolation, symptomatic monitoring of contacts as well as suspected and confirmed cases, and public health quarantine. In this context, telemedicine, particularly video consultations, has been promoted and scaled up to reduce the risk of transmission, especially in the United Kingdom and the United States of America. Based on a literature review, the first conceptual framework for telemedicine implementation during outbreaks was published in 2015. An updated framework for telemedicine in the COVID-19 pandemic has been defined. This framework could be applied at a large scale to improve the national public health response. Most countries, however, lack a regulatory framework to authorize, integrate, and reimburse telemedicine services, including in emergency and outbreak situations. In this context, Italy does not include telemedicine in the essential levels of care granted to all citizens within the National Health Service, while France authorized, reimbursed, and actively promoted the use of telemedicine. Several challenges remain for the global use and integration of telemedicine into the public health response to COVID-19 and future outbreaks. All stakeholders are encouraged to address the challenges and collaborate to promote the safe and evidence-based use of telemedicine during the current pandemic and future outbreaks. For countries without integrated telemedicine in their national health care system, the COVID-19 pandemic is a call to adopt the necessary regulatory frameworks for supporting wide adoption of telemedicine.","JMIR Public Health Surveill","Ohannessian, Robin","Duong, Tu Anh","Odone, Anna","32238336"],"abstract":["On March 11, 2020, the World Health Organization declared the coronavirus disease 2019 (COVID-19) outbreak as a pandemic, with over 720,000 cases reported in more than 203 countries as of 31 March. The response strategy included early diagnosis, patient isolation, symptomatic monitoring of contacts as well as suspected and confirmed cases, and public health quarantine. In this context, telemedicine, particularly video consultations, has been promoted and scaled up to reduce the risk of transmission, especially in the United Kingdom and the United States of America. Based on a literature review, the first conceptual framework for telemedicine implementation during outbreaks was published in 2015. An updated framework for telemedicine in the COVID-19 pandemic has been defined. This framework could be applied at a large scale to improve the national public health response. Most countries, however, lack a regulatory framework to authorize, integrate, and reimburse telemedicine services, including in emergency and outbreak situations. In this context, Italy does not include telemedicine in the essential levels of care granted to all citizens within the National Health Service, while France authorized, reimbursed, and actively promoted the use of telemedicine. Several challenges remain for the global use and integration of telemedicine into the public health response to COVID-19 and future outbreaks. All stakeholders are encouraged to address the challenges and collaborate to promote the safe and evidence-based use of telemedicine during the current pandemic and future outbreaks. For countries without integrated telemedicine in their national health care system, the COVID-19 pandemic is a call to adopt the necessary regulatory frameworks for supporting wide adoption of telemedicine."],"journal":"JMIR Public Health Surveill","authors":["Ohannessian, Robin","Duong, Tu Anh","Odone, Anna"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32238336","week":"202014|Mar 30 - Apr 05","doi":"10.2196/18810","keywords":["COVID-19","SARS-CoV-2","coronavirus","digital health","digital medicine","outbreak","pandemic","public health","surveillance","telehealth","telemedicine"],"source":"PubMed","locations":["United Kingdom","France","Italy"],"countries":["Italy","United Kingdom","France"],"countries_codes":["ITA|Italy","GBR|United Kingdom","FRA|France"],"topics":["Prevention"],"weight":1,"_version_":1662996001801109505,"score":98.65144}]}